IRON logo

DISC MEDICINE INC

IRONNASDAQ
πŸ† #1620 by market capUS Equity
$82.82β–Ό $0.35 (βˆ’0.42%)
After hours Β· at close
πŸ””
Track IRON
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.4%
7dβ–² 10.3%
14dβ–² 46.3%
30dβ–² 25.6%
ytdβ–² 4.3%
1yβ–Ό 2.7%
🏦Market Cap
$3.67B
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$82.28 – $84.87
52-Week Range
$40.00 – $99.50
Volume (shares)
42,133
Avg Volume (shares)
β€”
Shares Outstanding
44.4M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
β€”
P/E Ratio
β€”
P/S Ratio
β€”
EPS (TTM)
$-6.57
Dividend Yield
β€”
Dilution (1yr)
+17.9%
IRON logo

DISC MEDICINE INC

IRON
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0β–² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$236Mβ–² +81.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$181Mβ–² +92.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
35.3Mβ–² +17.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$89Mβ–Ό βˆ’$73M YoY
StockOtter Β· stockotter.space

About DISC MEDICINE INC

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.